Back
Reata Pharmaceuticals Quote, Financials, Valuation and Earnings
Sell
29
RETA
Reata Pharmaceuticals
Last Price:
25.15
Seasonality Move:
0.48%
7 Day Trial
ALL ACCESS PASS
$
7
Reata Pharmaceuticals Price Quote
$25.15
+0.02 (+0.48%)
(Updated: October 1, 2022 at 5:37 AM ET)
Reata Pharmaceuticals Key Stats
Sell
29
Reata Pharmaceuticals (RETA)
is a Sell
Day range:
$24.68 - $25.95
52-week range:
$18.47 - $114.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
91.51
P/B ratio:
13.36%
Volume:
579.3K
Avg. volume:
973.7K
1-year change:
-75.02%
Market cap:
$917.2M
Revenue:
$11.5M
EPS:
$-8.37
How Much Does Reata Pharmaceuticals Make?
-
How Much Are Reata Pharmaceuticals's Sales Annually?
RETA Revenues are $11.5M -
How Much Profit Does Reata Pharmaceuticals's Make A Year?
RETA net income is -$297.4M
Is Reata Pharmaceuticals Growing As A Company?
-
What Is Reata Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.66% -
What Is Reata Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Reata Pharmaceuticals Stock Price Performance
-
Did Reata Pharmaceuticals Stock Go Up Last Month?
Reata Pharmaceuticals share price went up by 4.66% last month -
Did RETA's Share Price Rise Over The Last Year?
RETA share price fell by -75.02% over the past 1 year
What Is Reata Pharmaceuticals 52-Week High & Low?
-
What Is Reata Pharmaceuticals’s 52-Week High Share Price?
Reata Pharmaceuticals has traded as high as $114.80 over the past 52 weeks -
What Is Reata Pharmaceuticals’s 52-Week Low Share Price?
Reata Pharmaceuticals has traded as low as $18.47 over the past 52 weeks
Reata Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Reata Pharmaceuticals?
-
How Much Debt Does Reata Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Reata Pharmaceuticals Have?
Cash and short term investments quarterly total is $481.5M -
What Is Reata Pharmaceuticals’s Book Value Per Share?
Book value per share is 1.88
Is Reata Pharmaceuticals Cash Flow Positive?
-
What Is RETA Cash Flow From Operations?
Cash flow from operations (TTM) is -$272.4M -
What Is Reata Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.2M -
What Is Reata Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$337.4M
Reata Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
RETA return on invested capital is -159.96% -
What Is Reata Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -42.83% -
What Is RETA Return On Equity?
ROE is a measure of profitability and is -159.96%
Reata Pharmaceuticals Earnings Date & Stock Price
-
What Is Reata Pharmaceuticals's Stock Price Today?
A single share of RETA can be purchased today for 25.13 -
What Is Reata Pharmaceuticals’s Stock Symbol?
Reata Pharmaceuticals trades on the nasdaq under the ticker symbol: RETA -
When Is Reata Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Reata Pharmaceuticals is scheduled on November 8, 2022 -
When Is RETA's next ex-dividend date?
Reata Pharmaceuticals's next ex-dividend date is October 2, 2022 -
How To Buy Reata Pharmaceuticals Stock?
You can buy Reata Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Reata Pharmaceuticals Competitors
-
Who Are Reata Pharmaceuticals's Competitors?
Below is a list of companies who compete with Reata Pharmaceuticals or are related in some way:
Reata Pharmaceuticals Dividend Yield
Data Unavailable
Reata Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 29.53% |
| Revenue: | -65.69% | -47.9% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 50.67 |
| Upside from Last Price: | 101.62% |